Clinical Trial: Cell Therapy in Dilated Cardiomyopathy: Observational Study
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: Cell Therapy in Dilated Cardiomyopathy: A Safety and Feasibility Study Using Autologous Bone Marrow Mononuclear Cells
Brief Summary: Using bone marrow mononuclear cell in 24 patients with Idiopathic dilated cardiomyopathy
Detailed Summary: Patients with Idiopathic dilated cardiomyopathy class II to IV NYHA with ejection fraction <35% were selected for phase I clinical trial of bone marrow mononuclear cell delivery in the coronary arteries and followed for 6 months
Sponsor: Ministry of Health, Brazil
Current Primary Outcome: echocardiography [ Time Frame: 2 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Ministry of Health, Brazil
Dates:
Date Received: January 23, 2008
Date Started: February 2005
Date Completion:
Last Updated: January 29, 2008
Last Verified: January 2008